The Mental Health Clinical Research Center at NYU is a facility in the medical school that has enabled investigators to work together to improve our understanding and treatment of three major psychiatric illnesses: organic mental syndrome, affective disorders and schizophrenia. Specifically, the Center was organized in order to: (1) provide strong and effective leadership in the development of collaborative studies involving clinical investigators and basic scientists, (2) develop control procedures to insure that the best possible research is carried out, (3) provide CORE resources to investigators in the Center in order to facilitate research design, diagnostic and behavioral assessment, statistical analysis and access to a computer facility, (4) provide CORE laboratories to investigators in the Center so that specialized tests and procedures can be carried out in conjunction with clinical and basic science studies, (5) provide seed money in order to encourage quality pilot proposals, particularly by young investigators, (6) facilitate recruitment of normal volunteers, symptomatic volunteers and patient volunteers, (7) provide a setting in which both didactic and preceptor type training can be provided to students, postgraduates and other relevant groups, (8) provide an institutional framework for the training and development of young investigators, (9) establish a resource, in the designed areas of interest of the Center, for the school, the community and the broader scientific community and the region and (10) carry out periodic rigorous external review and criticism in order to maintain the most effective leadership and quality of scientific research.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (SRCM (M5))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Schools of Medicine
New York
United States
Zip Code
Kring, A M; Alpert, M; Neale, J M et al. (1994) A multimethod, multichannel assessment of affective flattening in schizophrenia. Psychiatry Res 54:211-22
Serper, M R; Harvey, P D (1994) The need to integrate neuropsychological and experimental schizophrenia research. Schizophr Bull 20:1-11;discussion 13-21
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1994) Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 49:663-7
Spencer, E K; Alpert, M; Pouget, E R (1994) Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS. Psychopharmacol Bull 30:199-202
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1993) A mechanism underlying neuroleptic induced oral dyskinesias in rats. Pol J Pharmacol 45:391-8
Franssen, E H; Kluger, A; Torossian, C L et al. (1993) The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. Arch Neurol 50:1029-39
Silva, R R; Friedhoff, A J; Alpert, M (1993) Neuroleptic withdrawal psychosis in Tourette's disorder. Biol Psychiatry 34:341-2
Thompson, M A; Lee, E; Lawe, D et al. (1992) Nerve growth factor-induced derepression of peripherin gene expression is associated with alterations in proteins binding to a negative regulatory element. Mol Cell Biol 12:2501-13
Wu, J; Filer, D; Friedhoff, A J et al. (1992) Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. J Biol Chem 267:25754-8
Metz, R; Ziff, E (1991) cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 5:1754-66

Showing the most recent 10 out of 59 publications